Mark A. Rosenberg
Mark A. Rosenberg
Dr. Rosenberg is the founder and medical director of the AMT's Institute for Healthy Aging and Integrative Cancer Therapeutics, which together integrate traditional western medicine and the latest science with complementary and alternative medicine to optimize patients' health. Dr. Rosenberg received his undergraduate degree from the University of Pennsylvania and his doctorate in medicine from Georgetown University School of Medicine. He then completed his residency and board certification in emergency medicine in San Antonio, Texas, at Brooke Army Medical Center, where he was recognized with the "Teacher and Resident of the Year" award.
Dr. Rosenberg then began his career as an accomplished emergency physician and medical professor, first in the army where he achieved the rank of major, and then with a number of leading hospitals. However, after a decade of practice, he began to question some of the traditional standards of care that he had been taught in his medical training, because they were not meeting the needs of his patients.
Since that time over a decade ago, Dr. Rosenberg has become a leading researcher and clinician in the areas of healthy aging and integrated cancer therapy. He has dedicated his career to improving the aging process for men and women, as well as the care and outcomes for both early stage and terminal cancer patients. He and his staff have developed a reputation for solving aging and cancer challenges facing his patients that have not been successfully addressed by traditional medicine using the latest medical and nutritional science, as well as innovative therapies.
Dr. Rosenberg serves on the board of directors for the American Academy of Anti-Aging medicine, and is an advisor and lecturer for the academy, as well as the program director of the United States first Integrative Cancer Therapy Fellowship. In addition to being an astute clinician, Dr. Rosenberg is a research scientist, and is actively involved in the development of drugs and techniques to combat cancer, obesity, and age-related diseases. He holds a patent-pending on a unique drug for obesity, a novel nanoparticle, as well as a patent-pending for a cancer "cocktail," designed to specifically attack resistant cancer cells.
Georgette Schwartz, MSHN
Georgette Schwartz, MSHN
Georgette Schwartz has been a nutrition and fitness educator and specialist focusing on complete mental and physical well-being for over 20 years. What started as a passionate interest has turned into a dream career for Georgette, who serves as the Director of Nutrition Services at AMT’s Institute for Healthy Aging and Integrative Cancer Therapeutics. There, Georgette is focused on preparing customized nutrition, exercise and supplement programs for healthy aging patients who want to optimize their health and energy as well as those challenged by cancer, and other health conditions including cardio-metabolic syndrome, hormone imbalances, digestive issues, weight issues, diabetes, low energy and food allergies.
Through her own experience of avoiding a hysterectomy with dietary & lifestyle changes, Georgette became inspired to help others, and is a devoted and thorough student and practitioner of the healing arts. She is continuously seeking an ever-deepening understanding and application of the principals of nutrition and health, and is especially eager to explore the connections between conventional nutritional knowledge and broader perspectives, including natural health. Intuitive and attentive, Georgette is always ready to support her clients in their healing journeys to the fullest extent of their interest; she is compassionate and considerate, deeply caring and trustworthy, and has an unwavering commitment to her client’s success.
Georgette holds her Masters of Science in Holistic Nutrition from Hawthorn University in northern California, and is a candidate for receiving national board certification. Her thesis was on the Role of the Ketogenic Diet in the Fight against Cancer. She achieved her Bachelors of Business Administration from the prestigious American University in Washington D.C., and is a licensed fitness trainer through the Aerobic and Fitness Association of America (AFAA). Georgette is also a Certified Healthcare Practitioner in Metagenics® First Line Therapy® - the high-quality supplement line. Georgette is a Certified GAPS Practitioner and a Certified Gluten Practitioner.
Georgette has numerous other professional associations including the International & American Association of Clinical Nutritionists (IAACN), and the National Association of Nutrition Professionals (NANP). She is also an active member of the Institute for Functional Medicine (IFM).
As a member of the community, Georgette gives her time generously. She is a retired board member of Aid to Victims of Domestic Abuse (AVDA), and a regular speaker at Wellington Regional Hospital Cancer Support Group. Georgette speaks weekly at the Regency Health Center & Spa in Hollywood, Florida. She spoke at the A4M Integrative Cancer Symposium in Phoenix, AZ in April of 2012, and currently lectures for the Integrative Cancer Fellowship on Nutrition for Cancer. Georgette serves on the board of The Community Oncology Alliance as the Florida State representative.
Jason Williams, MD
Jason Williams, MD
Dr. Jason R. Williams is a medical doctor and board certified radiologist and pioneer in minimally invasive, image-guided cancer therapies, especially Cryoablation combined with injection of immunotherapy into the cancer. He obtained his medical doctorate from Louisiana State University. He completed an internship in internal medicine, followed by a residency in radiology at the University of South Alabama. He was selected for the Radiological Society of North America research and fellow award in 2004. In 2006, he won a Telly award for a video explaining ablation of cancer. He speaks at numerous national and international conferences. Also, he has trained doctors on image-guided cancer therapy in the USA, Mexico and South Africa. Dr. Williams’ research interest is in cancer immunotherapy combined with image guided ablation and gene therapy.